Salvatore Mirto

Fludarabine, cytarabine, and G-CSF (FLAG) for the treatment of poor risk acute myeloid leukemia

Marco Montillo, Salvatore Mirto, Maria Concetta Petti et al. · American Journal of Hematology · 1998 · 134 citations · Full text

Medicine, Hematology, Pharmacotherapy +15

Acute megakaryoblastic leukemia: experience of GIMEMA trials

Livio Pagano, Alessandro Pulsoni, Marco Vignetti et al. · Leukemia · 2002 · 99 citations

Medicine, Hematology, Oncology +13

Prolonged survival in poor-risk diffuse large B-cell lymphoma following front-line treatment with rituximab-supplemented, early-intensified chemotherapy with multiple autologous hematopoietic stem cell support: a multicenter study by GITIL (Gruppo Italiano Terapie Innovative nei Linfomi)

Corrado Tarella, Manuela Zanni, Massimo Di Nicola et al. · Leukemia · 2007 · 70 citations

Medicine, Hematology, Oncology +13

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Paola Tacchetti, Lucia Pantani, Francesca Patriarca et al. · The Lancet Haematology · 2020 · 58 citations

Medicine, Hematology, Pharmacotherapy +17

Serum LDH value as a predictor of clinical outcome in acute myelogenous leukaemia of the elderly

Felicetto Ferrara, Salvatore Mirto · British Journal of Haematology · 1996 · 52 citations

Medicine, Geriatric Medicine, Oncology +12